"Expensive" share?

-
Sometime back, I overheard this conversation:

Jane: Oh, this share's price is now $32. Should I sell it?
John: How much did you buy it for?
Jane: Think it was $18.
John: Wah better sell. It's expensive now.
Jane: Really? I'm reluctant. Moreover, it provides dividends.
John: Better sell.

Interesting. I was tempted to ask John how did he conclude that the share now is "expensive"?

If, for example, during this run up of share price (probably 4-5 years) the company has increased its earnings in similar fashion, is its share price still considered expensive? This points to analysis of its Price-Earning Ratio (P/E ratio).

Moreover, this particular company enjoys a degree of dominance in the market it is in and has been doing so for decades already. It has wide economic moat. It has not been embroiled in any major failings. This points to fundamental analysis.

Is it really wise to sell its share?

To be honest, I can't answer that from a short-term trader point of view. However, for me, as a long-term investor (as I would like to consider myself to be so), I would have held on and enjoy the dividends since I believed the company will still have its wide economic moat at least for the near-to-medium term.

Comments

Post a Comment

Popular posts from this blog

Fell Seal: Arbiter's Mark - character build (Part 1)

-
Here are the character builds for my current run (with the help of Ban): Kyrie Fellblade/Marked Counter: Slow Secondary passives: Execute, Life Font Fellblade itself is a good class because of the various conditions it can inflict and most importantly they can inflict Sleep. Iirc, the only other human class that can do this is Gadgeteer. Their passive Malice increases the chance of landing it by 10%. Fellblade pairs well with Marked because both use ATK and MND in their offensive abilities. Also, Fellblade's abilities are mostly short range whereas Marked has some long range abilities. Execute for more damage. Life Font is for suvivability. Ban opined that with two healers, there's no need for Life Font but I discover that it enables Kyrie to survive just enough for a healer to heal her up, after having received massive damage. Ban advocated for Marked/Fellblade for superior Speed (1.00 vs 0.92) and defense (heavy armor). I resisted this for a long time because I
Read more

Fell Seal: Arbiter's Mark - character build (Part 2)

-
(continue from Part 1 ) Yates Anatomist/Wizard Counter: Cripple Secondary passives: Blessed One, Smart Casting Anatomist is the best healer in game due to the passive Legendary Healer, which also then boost the amount of self-healing by Blessed One. Although Ban thinks Anatomist's Dark spells are sufficient in dealing damage and so he suggests Alchemyst as Yate's secondary class, I choose Wizard for the following reasons: Quite often, demonic creatures have Dark immunity and other creatures have immunity to other elements. So having Dark, Water, Fire, Earth and Thunder spells enable Yates to cast the most suitable spell, especially when the enemies are vulnerable to certain elements. Flexible casting :) Smart Casting is useful so that I don't need to worry much about the positioning of the enemies relative to my other characters when using Mass Healing and the area effect damage spells. As stated in previous post , there "are so many devastating Skill ba
Read more

Strange expectorant

-
Image
An expectorant cough syrup helps you to prevent phlegem from going to your lungs by expelling it via coughing or so I heard from doctors and pharmacists. That's why for cough that's caused by phlegm, it is not advisable to take suppressant cough syrup. Given that's the role, do you expect it to be drowsy? It should be non-drowsy so that you will be actively coughing out the phlegm, right? Not this Unizet expectorant. The doctor told me that it shouldn't be drowsy and yet some of his patients (including me) reported otherwise. I read the detailed information (on the piece of paper typically stuffed inside the box) and nowhere it indicated drowsiness as a side effect. Strange, huh?
Read more